Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline
Figure 3
Histopathologic photographs of cornea after chemical burn. (a) Normal cornea. (b) An example of topically tigecycline-treated eyes revealing less corneal neovascularization. (c) Subconjunctivally tigecycline-treated eyes showing virtually few neovascularization than in control group in stroma. (d) Diffuse and intense neovascularization affecting deep stromal layers after in control eyes.
